Brief: Cns Pharmaceuticals- Update On Progress For U.S. Manufacturing Of Berubicin

CNS Pharmaceuticals

03/09/2020 13:03

Sept 3 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS INC - UPDATE ON PROGRESS FOR U.S.
MANUFACTURING OF BERUBICIN
    * CNS PHARMACEUTICALS -  CO AND PII AGREED ON MANUFACTURING
PROCEDURE AND PACKAGING COMPONENTS FOR BERUBICIN, SELECTED A
STERILE FILTER MANUFACTURER
    * CNS PHARMACEUTICALS -  CO AND PII COMPLETED A SUCCESSFUL
LABORATORY SIMULATION OF LYOPHILIZATION CYCLE
    * CNS PHARMACEUTICALS INC - EXPECTS TO BEGIN MANUFACTURING
OF
BERUBICIN AT PII DURING Q3 OF THIS YEAR
    * CNS PHARMACEUTICALS INC - PLANS TO FILE AN IND FOR
BERUBICIN
WITH FDA DURING Q4 OF 2020

Source text for Eikon:  ID:nPn2M9GPza 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))